Ellen Xia

1.3k total citations
13 papers, 296 citations indexed

About

Ellen Xia is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Ellen Xia has authored 13 papers receiving a total of 296 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hepatology, 7 papers in Epidemiology and 6 papers in Infectious Diseases. Recurrent topics in Ellen Xia's work include Hepatitis C virus research (12 papers), Hepatitis B Virus Studies (6 papers) and HIV/AIDS drug development and treatment (6 papers). Ellen Xia is often cited by papers focused on Hepatitis C virus research (12 papers), Hepatitis B Virus Studies (6 papers) and HIV/AIDS drug development and treatment (6 papers). Ellen Xia collaborates with scholars based in United States, China and Slovakia. Ellen Xia's co-authors include Robert A. Chase, Angela Skelton, Zhiyong Guo, F. George Njoroge, Andrew Prongay, Xinchun Tong, Viyyoor Girijavallabhan, Stéphane Bogen, Anil K. Saksena and Xiao Tong and has published in prestigious journals such as Nucleic Acids Research, Biochemistry and Journal of Virology.

In The Last Decade

Ellen Xia

12 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ellen Xia United States 9 271 205 167 35 24 13 296
Lubna Ghanem Denmark 7 317 1.2× 284 1.4× 93 0.6× 50 1.4× 27 1.1× 7 344
Roel Sentjens Netherlands 8 344 1.3× 305 1.5× 114 0.7× 49 1.4× 29 1.2× 12 400
Sanne B. Jensen Denmark 8 312 1.2× 289 1.4× 91 0.5× 60 1.7× 26 1.1× 9 341
Katrien Vermeiren Sweden 4 285 1.1× 222 1.1× 170 1.0× 29 0.8× 40 1.7× 5 346
Betty Peng United States 9 268 1.0× 241 1.2× 130 0.8× 27 0.8× 38 1.6× 13 294
U. Karey Germany 5 323 1.2× 259 1.3× 160 1.0× 17 0.5× 26 1.1× 6 339
Markus Zettler Germany 4 256 0.9× 203 1.0× 142 0.9× 14 0.4× 25 1.0× 8 285
Eileen Z. Zhang United States 8 529 2.0× 407 2.0× 303 1.8× 29 0.8× 41 1.7× 10 544
Susan Purdy United States 8 518 1.9× 422 2.1× 174 1.0× 39 1.1× 54 2.3× 9 578
Stacey Voss United States 6 140 0.5× 121 0.6× 86 0.5× 8 0.2× 27 1.1× 6 200

Countries citing papers authored by Ellen Xia

Since Specialization
Citations

This map shows the geographic impact of Ellen Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen Xia more than expected).

Fields of papers citing papers by Ellen Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen Xia. The network helps show where Ellen Xia may publish in the future.

Co-authorship network of co-authors of Ellen Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Ellen Xia. A scholar is included among the top collaborators of Ellen Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen Xia. Ellen Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
Asante‐Appiah, Ernest, Paul Ingravallo, Patricia McMonagle, et al.. (2019). Interplay of Amino Acid Residues at Positions 28 and 31 in NS5A Defines Resistance Pathways in Hepatitis C Virus Genotype 2. Antimicrobial Agents and Chemotherapy. 63(12). 2 indexed citations
3.
Lahser, Frederick, Stephanie Curry, Patricia McMonagle, et al.. (2016). The Combination of Grazoprevir, a Hepatitis C Virus (HCV) NS3/4A Protease Inhibitor, and Elbasvir, an HCV NS5A Inhibitor, Demonstrates a High Genetic Barrier to Resistance in HCV Genotype 1a Replicons. Antimicrobial Agents and Chemotherapy. 60(5). 2954–2964. 38 indexed citations
4.
Gu, Zhengxian, Jason D. Graci, Frederick Lahser, et al.. (2013). Identification of PTC725, an Orally Bioavailable Small Molecule That Selectively Targets the Hepatitis C Virus NS4B Protein. Antimicrobial Agents and Chemotherapy. 57(7). 3250–3261. 15 indexed citations
5.
Kong, Rong, Paul Ingravallo, Ying Zhai, et al.. (2012). 858 IN VITRO RESISTANCE ANALYSIS OF HCV NS5A INHIBITOR: MK-8742 DEMONSTRATES INCREASED POTENCY AGAINST CLINICAL RESISTANCE VARIANTS AND HIGHER RESISITANCE BARRIER. Journal of Hepatology. 56. S334–S335. 9 indexed citations
6.
Tong, Xiao, Ashok Arasappan, Frank Bennett, et al.. (2010). Preclinical Characterization of the Antiviral Activity of SCH 900518 (Narlaprevir), a Novel Mechanism-Based Inhibitor of Hepatitis C Virus NS3 Protease. Antimicrobial Agents and Chemotherapy. 54(6). 2365–2370. 30 indexed citations
7.
Qiu, Ping, Stephanie Curry, Zhiyong Guo, et al.. (2009). Identification of HCV protease inhibitor resistance mutations by selection pressure-based method. Nucleic Acids Research. 37(10). e74–e74. 36 indexed citations
8.
Chase, Robert A., Angela Skelton, Ellen Xia, et al.. (2009). A novel HCV NS3 protease mutation selected by combination treatment of the protease inhibitor boceprevir and NS5B polymerase inhibitors. Antiviral Research. 84(2). 178–184. 14 indexed citations
9.
Tong, Xiao, Ashok Arasappan, Frank Bennett, et al.. (2009). 967 PRECLINICAL CHARACTERIZATION OF SCH 900518, A NOVEL MECHANISM-BASED INHIBITOR OF HCV NS3 PROTEASE. Journal of Hepatology. 50. S351–S351.
10.
Tong, Xinchun, Stéphane Bogen, Robert A. Chase, et al.. (2008). Characterization of resistance mutations against HCV ketoamide protease inhibitors. Antiviral Research. 77(3). 177–185. 100 indexed citations
11.
Tong, Xiao, Zhuyan Guo, Jacquelyn Wright-Minogue, et al.. (2006). Impact of Naturally Occurring Variants of HCV Protease on the Binding of Different Classes of Protease Inhibitors. Biochemistry. 45(5). 1353–1361. 30 indexed citations
12.
Wang, Wenyan, Frederick Lahser, MinKyung Yi, et al.. (2003). Conserved C-Terminal Threonine of Hepatitis C Virus NS3 Regulates Autoproteolysis and Prevents Product Inhibition. Journal of Virology. 78(2). 700–709. 16 indexed citations
13.
Ingravallo, Paul, Frederick Lahser, Ellen Xia, et al.. (2001). Characterization of monoclonal antibodies that specifically recognize the palm subdomain of hepatitis C virus nonstructural protein 5B polymerase. Virus Research. 75(2). 179–187. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lubna Ghanem Breakdown of academic impact, for papers by Roel Sentjens Breakdown of academic impact, for papers by Sanne B. Jensen Breakdown of academic impact, for papers by Katrien Vermeiren Breakdown of academic impact, for papers by Betty Peng Breakdown of academic impact, for papers by U. Karey Breakdown of academic impact, for papers by Markus Zettler Breakdown of academic impact, for papers by Eileen Z. Zhang Breakdown of academic impact, for papers by Susan Purdy Breakdown of academic impact, for papers by Stacey Voss
Rankless by CCL
2026